Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Alopecia areata treatment varies, with no optimal method established yet.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The 60-second timed hair count is a reliable and simple way to measure hair shedding at home, showing older women tend to shed more hair than younger women.

Sunflower oil was found to promote hair growth in mice with hormone-induced hair loss.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Sudden, unusual hair loss may indicate serious underlying health issues.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

A young girl with skin and scalp conditions showed some improvement with treatment.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

An elderly man's hair grew back after a treatment that transferred healthy gut bacteria.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.